ATE537855T1 - Verfahren zur verhinderung operativer verwachsungen - Google Patents

Verfahren zur verhinderung operativer verwachsungen

Info

Publication number
ATE537855T1
ATE537855T1 AT04702483T AT04702483T ATE537855T1 AT E537855 T1 ATE537855 T1 AT E537855T1 AT 04702483 T AT04702483 T AT 04702483T AT 04702483 T AT04702483 T AT 04702483T AT E537855 T1 ATE537855 T1 AT E537855T1
Authority
AT
Austria
Prior art keywords
surgical adhesions
tissue
preventing surgical
biomaterial
preventing
Prior art date
Application number
AT04702483T
Other languages
English (en)
Inventor
Nicholas Oray
Daniel Mooradian
Original Assignee
Synovis Life Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synovis Life Technologies Inc filed Critical Synovis Life Technologies Inc
Application granted granted Critical
Publication of ATE537855T1 publication Critical patent/ATE537855T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Adhesives Or Adhesive Processes (AREA)
AT04702483T 2003-01-17 2004-01-15 Verfahren zur verhinderung operativer verwachsungen ATE537855T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/346,240 US7144588B2 (en) 2003-01-17 2003-01-17 Method of preventing surgical adhesions
PCT/US2004/000880 WO2004066965A2 (en) 2003-01-17 2004-01-15 Method of preventing surgical adhesions

Publications (1)

Publication Number Publication Date
ATE537855T1 true ATE537855T1 (de) 2012-01-15

Family

ID=32712096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04702483T ATE537855T1 (de) 2003-01-17 2004-01-15 Verfahren zur verhinderung operativer verwachsungen

Country Status (11)

Country Link
US (1) US7144588B2 (de)
EP (1) EP1635731B1 (de)
AT (1) ATE537855T1 (de)
AU (1) AU2004207454B2 (de)
CA (1) CA2513640C (de)
CY (1) CY1112850T1 (de)
DK (1) DK1635731T3 (de)
ES (1) ES2384504T3 (de)
PT (1) PT1635731E (de)
SI (1) SI1635731T1 (de)
WO (1) WO2004066965A2 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8016823B2 (en) 2003-01-18 2011-09-13 Tsunami Medtech, Llc Medical instrument and method of use
US7892229B2 (en) 2003-01-18 2011-02-22 Tsunami Medtech, Llc Medical instruments and techniques for treating pulmonary disorders
US6599526B2 (en) * 2000-08-18 2003-07-29 The University Of North Texas Health Science Center At Fort Worth Pericardial anti-adhesion patch
US7549987B2 (en) 2000-12-09 2009-06-23 Tsunami Medtech, Llc Thermotherapy device
US9433457B2 (en) 2000-12-09 2016-09-06 Tsunami Medtech, Llc Medical instruments and techniques for thermally-mediated therapies
US8444636B2 (en) 2001-12-07 2013-05-21 Tsunami Medtech, Llc Medical instrument and method of use
US20060047291A1 (en) * 2004-08-20 2006-03-02 Uptake Medical Corporation Non-foreign occlusion of an airway and lung collapse
ES2645340T3 (es) 2004-11-16 2017-12-05 Uptake Medical Technology Inc. Dispositivo de tratamiento pulmonar
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US20060251702A1 (en) * 2005-05-05 2006-11-09 Cook Biotech Incorporated Implantable materials and methods for inhibiting tissue adhesion formation
US20070032785A1 (en) 2005-08-03 2007-02-08 Jennifer Diederich Tissue evacuation device
CA2626014C (en) * 2005-10-18 2012-07-10 Cook Biotech Incorporated Medical device with affixation means
US8585645B2 (en) * 2006-11-13 2013-11-19 Uptake Medical Corp. Treatment with high temperature vapor
US7993323B2 (en) 2006-11-13 2011-08-09 Uptake Medical Corp. High pressure and high temperature vapor catheters and systems
US20080241270A1 (en) * 2007-03-30 2008-10-02 Neal Robert A Fluid composition for inhibiting surgical adhesion formation and related method of production
WO2009009398A1 (en) 2007-07-06 2009-01-15 Tsunami Medtech, Llc Medical system and method of use
US8221401B2 (en) 2007-08-23 2012-07-17 Aegea Medical, Inc. Uterine therapy device and method
JP2011500281A (ja) 2007-10-22 2011-01-06 アップテイク・メディカル・コーポレイション 患者に特有の蒸気処置及び供給パラメータを決定する方法
US8322335B2 (en) 2007-10-22 2012-12-04 Uptake Medical Corp. Determining patient-specific vapor treatment and delivery parameters
US20090163936A1 (en) * 2007-12-21 2009-06-25 Chunlin Yang Coated Tissue Engineering Scaffold
US9924992B2 (en) 2008-02-20 2018-03-27 Tsunami Medtech, Llc Medical system and method of use
US20100082113A1 (en) 2008-04-29 2010-04-01 Peter Gingras Tissue repair implant
US8721632B2 (en) 2008-09-09 2014-05-13 Tsunami Medtech, Llc Methods for delivering energy into a target tissue of a body
US8579888B2 (en) 2008-06-17 2013-11-12 Tsunami Medtech, Llc Medical probes for the treatment of blood vessels
DE112009002177B4 (de) * 2008-10-03 2018-01-11 Replication Medical, Inc. Blutgefäß-Schutzvorrichtung
US20100094270A1 (en) 2008-10-06 2010-04-15 Sharma Virender K Method and Apparatus for Tissue Ablation
US10695126B2 (en) 2008-10-06 2020-06-30 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue
US9561066B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US10064697B2 (en) 2008-10-06 2018-09-04 Santa Anna Tech Llc Vapor based ablation system for treating various indications
US9561068B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US11284931B2 (en) 2009-02-03 2022-03-29 Tsunami Medtech, Llc Medical systems and methods for ablating and absorbing tissue
US8900223B2 (en) 2009-11-06 2014-12-02 Tsunami Medtech, Llc Tissue ablation systems and methods of use
US9161801B2 (en) 2009-12-30 2015-10-20 Tsunami Medtech, Llc Medical system and method of use
US9943353B2 (en) 2013-03-15 2018-04-17 Tsunami Medtech, Llc Medical system and method of use
US9743974B2 (en) 2010-11-09 2017-08-29 Aegea Medical Inc. Positioning method and apparatus for delivering vapor to the uterus
EP2763617B1 (de) 2011-10-07 2017-12-06 Aegea Medical Inc. Integritätstestvorrichtung zur abgabe von dampf in den uterus
US9162011B2 (en) 2011-12-19 2015-10-20 Allosource Flowable matrix compositions and methods
US20140120057A1 (en) 2012-10-25 2014-05-01 Rutgers, The State University Of New Jersey Polymers and methods thereof for wound healing
EP2945556A4 (de) 2013-01-17 2016-08-31 Virender K Sharma Verfahren und vorrichtung zur gewebeableitung
US9526602B1 (en) * 2013-03-15 2016-12-27 Anne Piche-Radley Method of applying adhesion barriers
WO2014150784A1 (en) 2013-03-15 2014-09-25 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
CA2923741C (en) 2013-09-19 2022-06-07 Microvention, Inc. Polymer films
US9546236B2 (en) 2013-09-19 2017-01-17 Terumo Corporation Polymer particles
AU2014240225A1 (en) 2013-10-01 2015-04-16 Uptake Medical Technology Inc. Preferential volume reduction of diseased segments of a heterogeneous lobe
US9688788B2 (en) 2013-11-08 2017-06-27 Terumo Corporation Polymer particles
US10179019B2 (en) 2014-05-22 2019-01-15 Aegea Medical Inc. Integrity testing method and apparatus for delivering vapor to the uterus
ES2991295T3 (es) 2014-05-22 2024-12-03 Coopersurgical Inc Sistemas para realizar la ablación endometrial
US10485604B2 (en) 2014-12-02 2019-11-26 Uptake Medical Technology Inc. Vapor treatment of lung nodules and tumors
US10531906B2 (en) 2015-02-02 2020-01-14 Uptake Medical Technology Inc. Medical vapor generator
US9907880B2 (en) 2015-03-26 2018-03-06 Microvention, Inc. Particles
CN109069064B (zh) 2016-02-19 2022-05-13 埃杰亚医疗公司 用于确定体腔的完整性的方法和设备
US12364537B2 (en) 2016-05-02 2025-07-22 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue
US11331140B2 (en) 2016-05-19 2022-05-17 Aqua Heart, Inc. Heated vapor ablation systems and methods for treating cardiac conditions
WO2018064390A1 (en) 2016-09-28 2018-04-05 Microvention, Inc. Polymer particles
US11129673B2 (en) 2017-05-05 2021-09-28 Uptake Medical Technology Inc. Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD
US11344364B2 (en) 2017-09-07 2022-05-31 Uptake Medical Technology Inc. Screening method for a target nerve to ablate for the treatment of inflammatory lung disease
US11350988B2 (en) 2017-09-11 2022-06-07 Uptake Medical Technology Inc. Bronchoscopic multimodality lung tumor treatment
USD845467S1 (en) 2017-09-17 2019-04-09 Uptake Medical Technology Inc. Hand-piece for medical ablation catheter
US11419658B2 (en) 2017-11-06 2022-08-23 Uptake Medical Technology Inc. Method for treating emphysema with condensable thermal vapor
US11490946B2 (en) 2017-12-13 2022-11-08 Uptake Medical Technology Inc. Vapor ablation handpiece
US11806066B2 (en) 2018-06-01 2023-11-07 Santa Anna Tech Llc Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems
US20240398462A1 (en) 2018-06-01 2024-12-05 Aqua Medical, Inc. Duodenal Ablation with Improved Depth and Consistency of Ablation
US11653927B2 (en) 2019-02-18 2023-05-23 Uptake Medical Technology Inc. Vapor ablation treatment of obstructive lung disease
US20220142729A1 (en) * 2020-11-06 2022-05-12 Carbon, Inc. Bioresorbable 3d printed adhesion barriers
CN116077739A (zh) * 2023-03-23 2023-05-09 杭州华迈医疗科技有限公司 一种脱细胞心包膜及其制备方法和用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991184A (en) 1973-10-05 1976-11-09 Martin Kludas Agent for the care of skin
US5059211A (en) 1987-06-25 1991-10-22 Duke University Absorbable vascular stent
US5085629A (en) 1988-10-06 1992-02-04 Medical Engineering Corporation Biodegradable stent
DE3835237C1 (de) 1988-10-15 1989-12-28 B. Braun Melsungen Ag, 3508 Melsungen, De
US4915113A (en) 1988-12-16 1990-04-10 Bio-Vascular, Inc. Method and apparatus for monitoring the patency of vascular grafts
US5258021A (en) 1992-01-27 1993-11-02 Duran Carlos G Sigmoid valve annuloplasty ring
US5411965A (en) 1993-08-23 1995-05-02 Arizona Board Of Regents Use of delta opioid receptor antagonists to treat cocaine abuse
GB9400163D0 (en) 1994-01-06 1994-03-02 Geistlich Soehne Ag Membrane
US5503638A (en) 1994-02-10 1996-04-02 Bio-Vascular, Inc. Soft tissue stapling buttress
JPH10503667A (ja) 1994-05-24 1998-04-07 スミス アンド ネフュー ピーエルシー 椎間板インプラント
US5783214A (en) 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
US5447922A (en) 1994-08-24 1995-09-05 Bristol-Myers Squibb Company α-phosphonosulfinic squalene synthetase inhibitors
US5837533A (en) 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
US5728152A (en) 1995-06-07 1998-03-17 St. Jude Medical, Inc. Bioresorbable heart valve support
CZ63699A3 (cs) 1996-08-28 1999-07-14 The Procter & Gamble Company Sloučeniny na bázi amidů kyseliny fosfinové jako inhibitory metaloprotáz mezibuněčné hmoty, způsob jejich přípravy a jejich použití jako léčiv
US6166184A (en) 1997-08-18 2000-12-26 Medtronic Inc. Process for making a bioprosthetic device
AU764536B2 (en) 1998-03-23 2003-08-21 Synovis Life Technologies, Inc. Implants and method of making
WO2000016822A1 (en) * 1998-09-21 2000-03-30 The Brigham And Women's Hospital, Inc. Compositions and methods for tissue repair
US6312474B1 (en) 1999-09-15 2001-11-06 Bio-Vascular, Inc. Resorbable implant materials

Also Published As

Publication number Publication date
WO2004066965A3 (en) 2006-01-05
EP1635731B1 (de) 2011-12-21
EP1635731A2 (de) 2006-03-22
AU2004207454A1 (en) 2004-08-12
US7144588B2 (en) 2006-12-05
ES2384504T3 (es) 2012-07-06
DK1635731T3 (da) 2012-04-16
CY1112850T1 (el) 2016-02-10
CA2513640A1 (en) 2004-08-12
CA2513640C (en) 2013-11-19
SI1635731T1 (sl) 2012-04-30
EP1635731A4 (de) 2009-11-18
AU2004207454B2 (en) 2010-03-04
WO2004066965A2 (en) 2004-08-12
US20040141956A1 (en) 2004-07-22
PT1635731E (pt) 2012-03-30

Similar Documents

Publication Publication Date Title
ATE537855T1 (de) Verfahren zur verhinderung operativer verwachsungen
MXPA04001334A (es) Materiales y metodos para promover la reparacion de tejido nervioso.
DK2174674T3 (da) Fremgangsmåder og sammensætninger til heling og reparation af led-brusk
DE60238416D1 (de) Plasmaprotein-matritzes und verfahren zu ihrer herstellung
ATE265241T1 (de) Resorbierbare implantatmaterialien
DK1715900T3 (da) Kompositstrukturer, som indeholder hyaluronsyre derivaterne deraf som nye knoglesubstitutter og -transplantater
BR0310011A (pt) Composição para reparar tecido, métodos para fabricar a mesma, para preparar tecido e para reparar um defeito tecidual em um paciente, composição injetável para reparar tecido, método para fabricar a mesma, e, dispositivo para reparar tecido
WO2002010348A3 (en) Tissue implant for cartilage repair
WO2003007786A3 (en) Porous delivery scaffold and method
WO2003011107A3 (en) Biologic replacement for fibrin clot
EP1471970A4 (de) Neue multipotente säugetier-stammzellen und zusammensetzungen, verfahren zur herstellung und verfahren zu ihrer verabreichung
WO2004078169A8 (en) Use of ep2 selective receptor agonists in medical treatment
UA88275C2 (ru) Композиция, которая включает остеогенный белок и фосфат кальция, которая имеет форму твердого штифта, пригодного для внутрикостной инъекции, способ ее получения и применения
DE10193003D2 (de) Verfahren zur Herstellung bioaktiver Implantatoberflächen
SG152297A1 (en) Composition for stimulating bone growth and differentiation and method for isolating same
ATE255920T1 (de) Methoden und zusammensetzungen zur heilung und reparatur von gelenkknorpeln
WO2005118014A3 (en) Decellurisation processes for making bioprotheses
EP1478354A4 (de) Verwendung von tgf-beta-antagonisten zur behandlung oder prävention von chronischer transplantatabstossung
WO2005020846A3 (en) Artificial bone and joint compositions and methods of use and manufacture
WO2007054939A3 (en) Method for non-autologous cartilage regeneration
CN107029298A (zh) 一种医用脱细胞真皮基质及其制备方法
WO2006011061A3 (en) Isolated muscle satellite cells, use thereof in muscle tissue repair and method for isolating said muscle satellite cells
DE602005008413D1 (de) Neuer radikalfänger mit einer viskoelastischen zusammensetzung; herstellungsverfahren und verpackung
AU2003251728A1 (en) Placental growth factor as a target for the treatment of osteoporosis
NO20032977L (no) Anvendelse av biologisk materiale inneholdende tredimensjonale oppsatsstrukturer av hyaluronsyrederivater for fremstilling av implantater i forbindelse med artroskopi.